natgillin/translations-raw huggingface dataset:
It has been established with respect to one or more representative uses of at least one plant protection product containing Clonostachys rosea strain J1446 that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
V zvezi z eno ali več reprezentativnimi uporabami vsaj enega fitofarmacevtskega sredstva, ki vsebuje Clonostachys rosea, sev J1446, je bilo ugotovljeno, da so merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 izpolnjena.
It is therefore appropriate to renew the approval of Clonostachys rosea strain J1446.
Zato je primerno obnoviti odobritev Clonostachys rosea, sev J1446.
The risk assessment for the renewal of the approval of Clonostachys rosea strain J1446 is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing Clonostachys rosea strain J1446 may be authorised.
Ocena tveganja za obnovitev odobritve Clonostachys rosea, sev J1446, temelji na omejenem številu reprezentativnih uporab, ki pa ne omejujejo uporab, za katere se fitofarmacevtska sredstva, ki vsebujejo Clonostachys rosea, sev J1446, lahko registrirajo.
The Commission further considers that Clonostachys rosea strain J1446 is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009.
Komisija poleg tega meni, da je Clonostachys rosea, sev J1446, aktivna snov z majhnim tveganjem v skladu s členom 22 Uredbe (ES) št. 1107/2009.
Clonostachys rosea strain J1446 is not a substance of concern and fulfils the conditions set in point 5 of Annex II to Regulation (EC) No 1107/2009.
Clonostachys rosea, sev J1446, ni problematična snov in izpolnjuje pogoje iz točke 5 Priloge II k Uredbi (ES) št. 1107/2009.
It is therefore appropriate to renew the approval of Clonostachys rosea strain J1446 as a low-risk substance.
Zato je primerno obnoviti odobritev Clonostachys rosea, sev J1446, kot snovi z majhnim tveganjem.
Commission Implementing Regulation (EU) 2018/917 extended the approval period of Clonostachys rosea strain J1446 to 31 July 2019 in order to allow the renewal process to be completed before the expiry date of the approval of that substance.
Z Izvedbeno uredbo Komisije (EU) 2018/917 je bilo podaljšano obdobje odobritve Clonostachys rosea, sev J1446, do 31. julija 2019, da bi se omogočil zaključek postopka obnovitve pred prenehanjem njegove odobritve.
However, given that a decision on renewal has been taken ahead of this extended expiry date, this Regulation shall apply from 1 April 2019.
Vendar ker je bil sklep o obnovitvi sprejet pred podaljšanim datumom prenehanja odobritve, bi se ta uredba morala uporabljati od 1. aprila 2019.
The approval of the active substance Clonostachys rosea strain J1446, as specified in Annex I, is renewed subject to the conditions laid down in that Annex.
Odobritev aktivne snovi Clonostachys rosea, sev J1446, kot je opredeljena v Prilogi I, se obnovi v skladu s pogoji iz navedene priloge.
It shall apply from 1 April 2019.
Uporablja se od 1. aprila 2019.
Commission Directive 2005/2/EC of 19 January 2005 amending Council Directive 91/414/EEC to include Ampelomyces quisqualis and Gliocladium catenulatum as active substances (OJ L 20, 22.1.2005, p. 15).
Direktiva Komisije 2005/2/ES z dne 19. januarja 2005 o spremembi Direktive Sveta 91/414/EGS zaradi vključitve Ampelomyces quisqualis in Gliocladium catenulatum kot aktivnih snovi (UL L 20, 22.1.2005, str. 15).
EFSA Journal 2016;14(7):4517, 16 pp. Available online: www.efsa.europa.eu.
EFSA Journal 2016;14(7):4517, 16 str. Na voljo na spletu: www.efsa.europa.eu.
Clonostachys rosea strain J1446
Clonostachys rosea, sev J1446
Accession number in the culture collection of the German Collection of Microorganisms and Cell Cultures (DSMZ): DSM 9212
Pristopna številka v zbirki kultur nemške zbirke mikroorganizmov in celičnih kultur (DSMZ): DSM 9212
Gliotoxin content: max.
Vsebnost gliotoksina: največ 50 μg/kg tehnične čistote MCPA.
50 μg/kg in the technical grade of the MCPA.
1. april 2019
1 April 2019
31. marec 2034
31 March 2034
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o obnovitvi Clonostachys rosea, sev J1446, ter zlasti dodatka I in II k poročilu.
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Clonostachys rosea strain J1446, and in particular Appendices I and II thereof, shall be taken into account.
V tej celoviti oceni morajo biti države članice zlasti pozorne na:
In this overall assessment Member States shall pay particular attention to:
specifikacijo tehničnega materiala, tržno predelanega v fitofarmacevtska sredstva, vključno s popolno opredelitvijo možnih metabolitov, ki vzbujajo zaskrbljenost;
the specification of technical material as commercially manufactured in plant protection products, including full characterisation of potential metabolites of concern;
zaščito izvajalcev in delavcev ob upoštevanju, da lahko mikroorganizmi povzročajo preobčutljivost, in zagotovitvi, da je med pogoji uporabe navedena uporaba ustrezne osebne zaščitne opreme;
the protection of operators and workers, taking into account that microorganisms are considered as potential sensitizers, ensuring that adequate personal protective equipment is included as a condition of use;
študije ali informacije iz znanstvene literature, ki so bile pred kratkim dane na voljo v zvezi s protiglivično občutljivostjo Clonostachys rosea J1446.
the studies or information from the scientific literature recently made available in relation to antifungal susceptibility of Clonostachys rosea J1446.
Proizvajalec zagotovi strogo vzdrževanje okoljskih razmer in analizo nadzora kakovosti med proizvodnim postopkom, da se izpolnijo omejitve glede mikrobiološke kontaminacije iz delovnega dokumenta SANCO/12116/2012.
Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer, in order to ensure the fulfilment of the limits on microbial contamination as referred to in the Working Document SANCO/12116/2012.
Pogoji uporabe po potrebi vključujejo ukrepe za zmanjšanje tveganja.
The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
v delu A se vnos 98 za Gliocladium catenulatum, sev J1446, črta;
in Part A, entry 98 on Gliocladium catenulatum strain J1446 is deleted;
v delu D se doda naslednji vnos:
in Part D, the following entry is added:
Pristopna številka v zbirki kultur nemške zbirke mikroorganizmov in celičnih kultur (DSMZ): DSM 9212
Accession number in the culture collection of the German Collection of Microorganisms and Cell Cultures (DSMZ): DSM 9212
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o obnovitvi Clonostachys rosea, sev J1446, ter zlasti dodatka I in II k poročilu.
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Clonostachys rosea strain J1446, and in particular Appendices I and II thereof, shall be taken into account.
https://ec.europa.eu/food/sites/food/files/plant/docs/pesticides_ppp_app-proc_guide_phys-chem-ana_microbial-contaminant-limits.pdf.“
amending Annex II to Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council
o spremembi Priloge II Delegirane uredbe Komisije (EU) št. 1062/2014 o delovnem programu za sistematično preverjanje vseh obstoječih aktivnih snovi, ki jih vsebujejo biocidni proizvodi, iz Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products and in particular the first subparagraph of Article 89(1) thereof,
ob upoštevanju Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta z dne 22. maja 2012 o dostopnosti na trgu in uporabi biocidnih proizvodov ter zlasti prvega pododstavka člena 89(1) Uredbe,
Commission Delegated Regulation (EU) No 1062/2014, as amended by Commission Delegated Regulation (EU) 2017/698, sets out in its Annex II a list of active substance/product-type combinations included in the programme of review of existing active substances contained in biocidal products on 3 February 2017.
Delegirana uredba Komisije (EU) št. 1062/2014, kakor je bila spremenjena z Delegirano uredbo Komisije (EU) 2017/698, v svoji Prilogi II določa seznam kombinacij aktivnih snovi/vrst proizvodov, vključenih v program pregledovanja obstoječih aktivnih snovi, ki jih biocidni proizvodi vsebujejo na dan 3. februarja 2017.
The identities of certain active substances listed in Annex II which can be generated in situ have been redefined pursuant to Article 13 of Delegated Regulation (EU) No 1062/2014 in order to indicate in a more precise manner the active substances and their precursors presently covered in the work programme for systematic examination.
Opisi nekaterih aktivnih snovi iz Priloge II, ki se lahko pridobijo in situ, so bili na novo opredeljeni v skladu s členom 13 Delegirane uredbe (EU) št. 1062/2014, z namenom natančnejše navedbe aktivnih snovi in njihovih predhodnih sestavin, ki so trenutno zajete v delovnem programu za sistematično preverjanje.
Any person with an interest could notify a combination of an active substance and its precursors not yet covered by the new identity.
Vsaka zainteresirana oseba bi lahko z novim opisom prijavila kombinacijo aktivne snovi in njenih predhodnih sestavin, ki še niso zajete.
Substance/product-type combinations notified pursuant to Article 14(1)(b) and found compliant by the European Chemicals Agency (the Agency) with Article 17(2) of the Delegated Regulation (EU) No 1062/2014 should be included in Annex II to that Regulation pursuant to its Article 18.
Kombinacije snovi/vrst proizvodov, ki so bile prijavljene v skladu s členom 14(1)(b) in za katere je Evropska agencija za kemikalije (v nadaljnjem besedilu: Agencija) ugotovila, da so v skladu s členom 17(2) Delegirane uredbe (EU) št. 1062/2014, bi bilo treba v skladu s členom 18 navedene uredbe vključiti v njeno prilogo II.
Following the declarations received pursuant to Article 16(4) of Delegated Regulation (EU) No 1062/2014, an invitation was published by the Agency where any person with an interest could notify active substances in product-type 19 that benefitted from the derogation for food and feed provided for by Article 6 of Commission Regulation (EC) No 1451/2007.
Agencija je glede na izjave, prejete v skladu s členom 16(4) Delegirane uredbe (EU) št. 1062/2014, objavila vabilo za vse zainteresirane osebe, da prijavijo aktivne snovi v vrsti proizvodov 19, ki so bili upravičeni do odstopanja za živila in krmo iz člena 6 Uredbe Komisije (ES) št. 1451/2007.
The substance/product-type combinations notified pursuant to Article 16(5) and found compliant by the Agency with Article 17(2) of the Delegated Regulation (EU) No 1062/2014 should be included in Annex II to that Regulation pursuant to its Article 18.
Kombinacije snovi/vrst proizvodov, ki so bile prijavljene v skladu s členom 16(5) in za katere je Agencija ugotovila, da so v skladu s členom 17(2) Delegirane uredbe (EU) št. 1062/2014, bi bilo treba v skladu s členom 18 navedene uredbe vključiti v njeno prilogo II.
It is appropriate to indicate the Member States the competent authorities of which shall be the evaluating competent authorities for the active substance/product-type combinations to be added to Annex II to Delegated Regulation (EU) No 1062/2014.
Navesti je treba pristojne organe držav članic, ki bodo ocenjevalni pristojni organi za kombinacije aktivnih snovi/vrst proizvodov in jih je treba dodati v Prilogo II k Delegirani uredbi (EU) št. 1062/2014.
Active substance/product-type combinations for which a decision of approval or non-approval has been taken after 3 February 2017 should no longer be included in Annex II to Delegated Regulation (EU) No 1062/2014.
Kombinacije aktivnih snovi/vrst proizvodov, za katere je bil po 3. februarju 2017 sprejet sklep o odobritvi ali neodobritvi, se ne bi smele vključiti v Prilogo II k Delegirani uredbi (EU) št. 1062/2014.
In order to reflect the actual situation and for reasons of legal certainty it is appropriate to provide a list of active substance/product-type combinations included in the programme of review of existing active substances contained in biocidal products on the day of adoption of this Regulation.
Glede na dejansko stanje in zaradi pravne varnosti je primerno zagotoviti seznam kombinacij aktivnih snovi/vrst proizvodov, vključenih v program pregledovanja obstoječih aktivnih snovi, ki jih vsebujejo biocidni proizvodi na dan sprejetja te uredbe.
Annex II to Delegated Regulation (EU) No 1062/2014 is replaced by the Annex to this Regulation.
Priloga II k Delegirani uredbi (EU) št. 1062/2014 se nadomesti s Prilogo k tej uredbi.
Commission Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 (OJ L 294, 10.10.2014, p. 1).
Uredba Komisije (EU) št. 1062/2014 z dne 4. avgusta 2014 o delovnem programu za sistematično preverjanje vseh obstoječih aktivnih snovi, ki jih vsebujejo biocidni proizvodi, iz Uredbe (EU) št. 528/2012 (UL L 294, 10.10.2014, str. 1).
Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (OJ L 103, 19.4.2017, p 1).
Delegirana uredba Komisije (EU) 2017/698 z dne 3. februarja 2017 o spremembi Delegirane uredbe Komisije (EU) št. 1062/2014 o delovnem programu za sistematično preverjanje vseh obstoječih aktivnih snovi, ki jih vsebujejo biocidni proizvodi, iz Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta o dostopnosti na trgu in uporabi biocidnih proizvodov (UL L 103, 19.4.2017, str. 1).
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p. 3).
Uredba Komisije (ES) št. 1451/2007 z dne 4. decembra 2007 o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet (UL L 325, 11.12.2007, str. 3).
SUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 6 NOVEMBER 2018
KOMBINACIJE SNOVI/VRST PROIZVODOV, VKLJUČENE V PROGRAM PREGLEDOVANJA 6.
Active substance/product-type combinations supported on 6 November 2018, excluding any other nanomaterial than those explicitly mentioned in entries 1017 and 1023, and excluding any generation in situ of the active substance except when explicitly mentioned with the reference to the supported precursor(s).
NOVEMBRA 2018
Entry number
Kombinacije aktivnih snovi/vrst proizvodov, podprte 6. novembra 2018, brez kakršnih koli nanomaterialov, ki niso bili izrecno navedeni v vnosih 1017 in 1023, pri čemer je izključeno kakršno koli pridobivanje aktivnih snovi in situ, razen kadar je to izrecno navedeno s sklicem na podprte predhodne sestavine (prekurzorje).
Substance name
Številka vnosa
Performic acid generated from formic acid and hydrogen peroxide
Peroksimravljična kislina, pridobljena iz mravljične kisline in vodikovega peroksida
Glycolic acid
Glikolna kislina
Peracetic acid generated from tetraacetylethylenediamine (TAED) and hydrogen peroxide
Perocetna kislina, pridobljena iz tetraacetil etilendiamina (TAED) in vodikovega peroksida
Peracetic acid generated from 1,3- diacetyloxypropan-2-yl acetate and hydrogen peroxide
Perocetna kislina, pridobljena iz 1,3-diacetiloksipropan-2-il acetata in vodikovega peroksida
Peracetic acid generated from tetraacetylethylenediamine (TAED) and sodium perborate monohydrate
Perocetna kislina, pridobljena iz tetraacetil etilendiamina (TAED) in natrijevega perborat monohidrata
Peracetic acid generated by perhydrolysis of N-acetylcaprolactam by hydrogen peroxide in alkaline conditions
Perocetna kislina, pridobljena s perhidrolizo N-acetilkaprolaktama z vodikovim peroksidom v alkalnih pogojih
Glyoxal
Heksa-2,4-dienojska kislina (sorbinska kislina)
Hexa-2,4-dienoic acid (Sorbic acid)
Klorofen
Chlorophene
2-fenoksietanol
2-Phenoxyethanol
Ogljikov dioksid
Carbon dioxide
Ogljikov dioksid, pridobljen iz propana, butana ali mešanice obeh s sežigom
Carbon dioxide generated from propane, butane or a mixture of both by combustion
Natrijev dimetilarzinat (natrijev kakodilat)
Sodium dimethylarsinate (Sodium Cacodylate)
Natrijev tozilkloramid (kloramin-T)
Tosylchloramide sodium (Chloramin T)
Kalijev metilditiokarbamat
Potassium dimethyldithiocarbamate
Natrijev metilditiokarbamat
Sodium dimethyldithiocarbamate
Natrijev 2-bifenilat
Thiram
Natrijev metam
Metam-sodium
2-tiazol-4-il-1H-benzoimidazol (tiabendazol)
2-Thiazol-4-yl-1H-benzoimidazole (Thiabendazole)
Cianamid
(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin)
2,2′-ditiobis[N-metilbenzamid] (DTBMA)
2,2′-Dithiobis[N-methylbenzamide] (DTBMA)
Natrijev dikloroizocianurat dihidrat
1,2-Benzisothiazol-3(2H)-one (BIT)
Troklozen natrij
2-Methyl-2H-isothiazol-3-one (MIT)
Mecetronijev etilsulfat (MES)
Sodium dichloroisocyanurate dihydrate
Formaldehid, ki se sprošča iz (etilendioksi) dimetanola (reakcijski produkti etilen glikola s paraformaldehidom (EGForm))
Troclosene sodium
Piridin-2-tiol 1-oksid, natrijeva sol (natrijev pirition)
Mecetronium ethylsulfate (MES)
Metenamin 3-kloroaliloklorid (CTAC)
Formaldehyde released from (Ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm))
2,2′,2″-(heksahidro-1,3,5-triazin-1,3,5-triil)trietanol (HHT)
Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)
Tetrahidro-1,3,4,6-tetrakis(hidroksimetil)imidazo[4,5-d]imidazol-2,5(1H,3H)-dion (TMAD)
Methenamine 3-chloroallylochloride (CTAC)
Metilen ditiocianat
2,2′,2″-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT)
1,3-bis(hidroksimetil)-5,5-dimetilimidazolidin-2,4-dion (DMDMH)
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD)
Didecildimetilamonijev klorid (DDAC)
Methylene dithiocyanate
Srebro
1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH)
Srebro kot nanomaterial
Didecyldimethylammonium chloride (DDAC)
Žveplov dioksid, pridobljen iz žvepla z zgorevanjem
Silver
Aktivni brom, pridobljen iz natrijevega bromida in natrijevega hipoklorita
Silver, as a nanomaterial
Aktivni brom, pridobljen iz natrijevega bromida in kalcijevega hipoklorita
Sulfur dioxide generated from sulfur by combustion
Aktivni brom, pridobljen iz natrijevega bromida in kora
Active bromine generated from sodium bromide and sodium hypochlorite
Aktivni brom, pridobljen iz natrijevega bromida z elektrolizo
Active bromine generated from sodium bromide and calcium hypochlorite
Aktivni brom, pridobljen iz hipobromove kisline ter sečnine in bromove sečnine
Active bromine generated from sodium bromide and chlorine
Aktivni brom, pridobljen iz natrijevega hipobromita in N-bromosulfamata ter sulfaminske kisline
Active bromine generated from sodium bromide by electrolysis
Aktivni brom, pridobljen iz ozona in bromida iz naravne vode ter natrijevega bromida
Active bromine generated from sodium hypobromite and N-bromosulfamate and sulfamic acid
Vodikov peroksid
Active bromine generated from ozone and bromide of natural water and sodium bromide
Vodikov peroksid, sproščen iz natrijevega perkarbonata
Tetramethrin
7a-etildihidro-1H,3H,5H-oksazolo[3,4-c]oksazol (EDHO)
Hydrogen peroxide
Srebrov nitrat
Hydrogen peroxide released from sodium percarbonate
Dinatrijev peroksodisulfat
7a-Ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO)
Aktivni klor, sproščen iz natrijevega hipoklorita
Silver nitrate
Aktivni klor, sproščen iz kalcijevega hipoklorita
Disodium peroxodisulfate
Aktivni klor, sproščen iz klora
Active chlorine released from sodium hypochlorite
Monokloramin, pridobljen iz amonijevega sulfata in vira klora
Active chlorine released from calcium hypochlorite
Srebrov klorid
Active chlorine released from chlorine
Piretrini in piretroidi
Monochloramine generated from ammonium sulfate and a chlorine source
Klorov dioksid
Silver chloride
Klorov dioksid, pridobljen iz natrijevega klorita z elektrolizo
Pyrethrins and Pyrethroids
Klorov dioksid, pridobljen iz natrijevega klorita z acidifikacijo
Chlorine dioxide
Klorov dioksid, pridobljen iz natrijevega klorita z oksidacijo
Chlorine dioxide generated from sodium chlorite by electrolysis
Klorov dioksid, pridobljen iz natrijevega klorata in vodikovega peroksida ob prisotnosti močne kisline
Chlorine dioxide generated from sodium chlorite by acidification
Klorov dioksid, pridobljen iz natrijevega klorita z elektrolizo
Chlorine dioxide generated from sodium chlorite by oxidation
Klorov dioksid, pridobljen iz natrijevega klorita in natrijevega bisulfata ter klorovodikove kisline
Chlorine dioxide generated from sodium chlorate and hydrogen peroxide in the presence of a strong acid
Klorov dioksid, pridobljen iz natrijevega klorita in natrijevega bisulfata
Chlorine dioxide generated from sodium chloride by electrolysis
Klorov dioksid, pridobljen iz natrijevega klorita in natrijevega persulfata
Chlorine dioxide generated from sodium chlorite and sodium bisulfate and hydrochloric acid
2,2-dibromo-2-cianoacetamid (DBNPA)
Chlorine dioxide generated from sodium chlorite and sodium persulfate
Dialuminijev klorid pentahidroksid
2,2-Dibromo-2-cyanoacetamide (DBNPA)
Z bromidom aktivirani kloramin (BAC), pridobljen iz prekurzorjev, tj. amonijevega bromida in natrijevega hipoklorita
Carbendazim
Cinkov pirition
Dialuminium chloride pentahydroxide
Dodecilgvanidinijev monohidroklorid
Bromide activated chloramine (BAC) generated from precursors ammonium bromide and sodium hypochlorite
Aktivni brom, pridobljen iz bromovega klorida
Pyrithione zinc
(Benziloksi)metanol
Dodecylguanidine monohydrochloride
D-glukonska kislina, spojina z N,N″-bis(4-klorofenil)-3,12-diimino-2,4,11,13-tetraazatetradekandiamidin (2:1) (CHDG)
Active bromine generated from bromine chloride
P-[(dijodometil)sulfonil]toluen
(Benzyloxy)methanol
(Benzotiazol-2-iltio)metil tiocianat (TCMTB)
D-Gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG)
2-metil-4-okso-3-(prop-2-inil)ciklopent-2-en-1-il 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (praletrin)
p-[(Diiodomethyl)sulphonyl]toluene
Kalijev (E,E)-heksa-2,4-dienoat (kalijev sorbat)
(Benzothiazol-2-ylthio)methyl thiocyanate (TCMTB)
Reakcijski produkti paraformaldehida in 2-hidroksipropilamina (v razmerju 1:1) (HPT)
Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate)
Dimetiloktadecil[3-(trimetoksisilil)propil]amonijev klorid
Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1) (HPT)
Bromokloro-5,5-dimetilimidazolidin-2,4-dion (BCDMH)
2-Octyl-2H-isothiazol-3-one (OIT)
3-(4-izopropilfenil)-1,1-dimetilsečnina (izoproturon)
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
1-[2-(aliloksi)-2-(2,4-diklorofenil)etil]-1H-imidazol (imazalil)
Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH)
S-[(6-kloro-2-oksooksazolo[4,5-b]piridin-3(2H)-il)metil] O,O-dimetil tiofosfat (azametifos)
3-(4-Isopropylphenyl)-1,1-dimethylurea (Isoproturon)
Dimetiltetradecil[3-(trimetoksisilil)propil]amonijev klorid
1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)
Eucalyptus citriodora olje, hidrirano, ciklizirano